Consolidated Construction Consortium Limited (NSE:CCCL)
India · Delayed Price · Currency is INR 16.32
-0.51 (-3.03%)
Aug 1, 2025, 3:29 PM IST
Ligand Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 2,051 | 1,820 | 1,308 | 1,393 | 1,306 | 2,037 | Upgrade | |
Revenue Growth (YoY) | 49.93% | 39.11% | -6.10% | 6.66% | -35.88% | -40.78% | Upgrade |
Cost of Revenue | 1,749 | 1,545 | 1,153 | 1,201 | 1,168 | 1,848 | Upgrade |
Gross Profit | 301.38 | 274.47 | 154.91 | 192.16 | 137.85 | 188.56 | Upgrade |
Selling, General & Admin | 293.53 | 274.99 | 638.26 | 188.23 | 226.01 | 301.19 | Upgrade |
Other Operating Expenses | 191.23 | 12.4 | -992.06 | 310.17 | -166.46 | 116.01 | Upgrade |
Operating Expenses | 666.43 | 476.2 | 6,128 | 562.72 | 777.71 | 572.53 | Upgrade |
Operating Income | -365.05 | -201.73 | -5,973 | -370.56 | -639.86 | -383.97 | Upgrade |
Interest Expense | -1.96 | -26.25 | -139.95 | -776.63 | -766.3 | -808.28 | Upgrade |
Interest & Investment Income | 355.71 | 355.71 | 17.24 | 9.03 | 0.16 | 16.05 | Upgrade |
Earnings From Equity Investments | 1.02 | 1.02 | 14.58 | 0.4 | -8.71 | -28.38 | Upgrade |
Other Non Operating Income (Expenses) | -112.22 | -112.22 | -23.74 | 1.61 | -5.6 | -4.32 | Upgrade |
EBT Excluding Unusual Items | -122.5 | 16.53 | -6,105 | -1,136 | -1,420 | -1,209 | Upgrade |
Gain (Loss) on Sale of Investments | 11.54 | 11.54 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -314.12 | - | 0.1 | -2.67 | Upgrade |
Asset Writedown | - | - | -248.49 | - | -0.38 | -9.88 | Upgrade |
Legal Settlements | -170.97 | -170.97 | - | - | - | - | Upgrade |
Other Unusual Items | 1,976 | 1,187 | 13,156 | - | - | 183.72 | Upgrade |
Pretax Income | 1,694 | 1,044 | 6,488 | -1,136 | -1,421 | -1,038 | Upgrade |
Income Tax Expense | 167.7 | 167.7 | -237.73 | -10.55 | -12.15 | -9.64 | Upgrade |
Earnings From Continuing Operations | 1,527 | 876.41 | 6,726 | -1,126 | -1,408 | -1,028 | Upgrade |
Earnings From Discontinued Operations | 154.8 | - | - | - | - | - | Upgrade |
Net Income | 1,682 | 876.41 | 6,726 | -1,126 | -1,408 | -1,028 | Upgrade |
Net Income to Common | 1,682 | 876.41 | 6,726 | -1,126 | -1,408 | -1,028 | Upgrade |
Net Income Growth | -75.81% | -86.97% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 411 | 407 | 399 | 399 | 399 | 399 | Upgrade |
Shares Outstanding (Diluted) | 411 | 407 | 399 | 399 | 399 | 399 | Upgrade |
Shares Change (YoY) | 1.44% | 2.05% | - | - | - | - | Upgrade |
EPS (Basic) | 4.09 | 2.16 | 16.88 | -2.82 | -3.53 | -2.58 | Upgrade |
EPS (Diluted) | 4.09 | 2.16 | 16.88 | -2.82 | -3.53 | -2.58 | Upgrade |
EPS Growth | -76.16% | -87.23% | - | - | - | - | Upgrade |
Free Cash Flow | - | 1,551 | 504.91 | -5.08 | 76.4 | 69.79 | Upgrade |
Free Cash Flow Per Share | - | 3.81 | 1.27 | -0.01 | 0.19 | 0.17 | Upgrade |
Gross Margin | 14.70% | 15.08% | 11.84% | 13.79% | 10.55% | 9.26% | Upgrade |
Operating Margin | -17.80% | -11.09% | -456.60% | -26.60% | -48.99% | -18.85% | Upgrade |
Profit Margin | 82.00% | 48.16% | 514.11% | -80.80% | -107.83% | -50.47% | Upgrade |
Free Cash Flow Margin | - | 85.21% | 38.59% | -0.36% | 5.85% | 3.43% | Upgrade |
EBITDA | -318.23 | -153.35 | -5,919 | -307.31 | -567.34 | -299.55 | Upgrade |
EBITDA Margin | -15.52% | -8.43% | - | -22.06% | -43.44% | -14.71% | Upgrade |
D&A For EBITDA | 46.82 | 48.38 | 54.63 | 63.25 | 72.53 | 84.43 | Upgrade |
EBIT | -365.05 | -201.73 | -5,973 | -370.56 | -639.86 | -383.97 | Upgrade |
EBIT Margin | -17.80% | -11.09% | - | -26.60% | -48.99% | -18.85% | Upgrade |
Effective Tax Rate | 9.90% | 16.06% | - | - | - | - | Upgrade |
Revenue as Reported | 2,644 | 2,409 | 1,362 | 1,433 | 1,362 | 2,305 | Upgrade |
Advertising Expenses | - | 0.25 | 0.3 | 0.2 | 0.33 | 0.47 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.